Skip to content

HPLC analysis published for every batchTHC < 0.3%Shipped from France10% off when you sign up

CHM-081

Synthetic molecule of the naphthoylindole family, analogue of JWH-081, classified as a narcotic in France under a generic clause.

Level of detail

C₂₇H₂₇NO₂

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Data sheet

Names

IUPAC name
[1-(cyclohexylmethyl)indol-3-yl]-(4-methoxynaphthalen-1-yl)methanone
Other names
1-(cyclohexylmethyl)-3-(4-methoxy-1-naphthoyl)indole

Identifiers

Formula
C₂₇H₂₇NO₂
Molar mass
397.50 g/mol
CAS
1373876-34-6
InChIKey
LMENRXZOUBANKQ-UHFFFAOYSA-N

Class

Family
Synthetic cannabinoid (SCRA)

Legal status

France
Narcotic: generic clause
International
Unscheduled
See the legal framework

Updated on

Receptors and activity

  1. CB1Agonist5 out of 100

    Aucune constante d'affinité publiée ; agonisme présumé par analogie avec le JWH-081, non mesuré pour ce composé

  2. CB2Agonist5 out of 100

    Aucune constante d'affinité publiée ; agonisme présumé par analogie avec le JWH-081, non mesuré pour ce composé

Bar length shows the relative strength of the interaction, as an indication.

Subjective signature

Calm
5 out of 100
Relaxation of body and mind; reduced mental noise without marked drowsiness.
Clarity
5 out of 100
Sustained attention and clear thinking; functional lucidity, not euphoria.
High
5 out of 100
Euphoria and sensory intensity; altered perception of time and space.
Appetite
5 out of 100
Stimulation of hunger and of taste appreciation (the “munchies” effect).
Sleep
5 out of 100
Sedative effect: aids sleep onset and the continuity of deep sleep.
Editorial estimate, not clinical.

Pharmacology

CHM-081 is a synthetic molecule of the naphthoylindole family, an analogue of JWH-081 in which the pentyl chain is replaced by a cyclohexylmethyl group. Blakey et al. (2016) report it in seized plant material packaged as herbal incense. The sources consulted give no affinity constant for CB1 or CB2, and no human pharmacokinetic or toxicological data. Its status in France rests on the generic clause of the indol-3-yl methanone family, not on a named mention.

History

Source
Synthetic molecule: no source consulted reports it in a plant or a living organism. It has been reported in seized plant material packaged as herbal incense.

Origin (pharmaceutical research → illicit market)

No biosynthetic route is described: CHM-081 belongs to synthetic chemistry, through attachment of a naphthoyl group at position 3 of an indole substituted on the nitrogen.

References

Structured data

SMILES
COC1=CC=C(C2=CC=CC=C21)C(=O)C3=CN(C4=CC=CC=C43)CC5CCCCC5
InChIKey
LMENRXZOUBANKQ-UHFFFAOYSA-N

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.